DNA
#2995
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
7.0 4 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.44%
Variación mensual
-13.19%
Variación en los últimos 6 meses
+2.77%
Cambio anual
-20.72%
Cierres anteriores
6.9 4
Open
7.0 1
Mínimo
6.9 6
Máximo
7.0 7
Volumen
450
Financials
- Market Capitalization 452.96 M
- Employee 485
- Founded 2008
- CEO Jason Kelly
- Website www.ginkgobioworks.com
- Headquarter Delaware, United States
- FIGI BBG00YPS1KY3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.98
Relación precio/flujo de caja
4.57
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2985 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.48 USD | +7.43% | +7.95% | +50.84% | +0.90% | 451.81 M USD | ||
| 2986 |  OCGN Ocugen, Inc. - Common Stock | 1.32 USD | -0.75% | -7.04% | +6.45% | +30.69% | 447.63 M USD | ||
| 3006 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 5.43 USD | -1.09% | -13.12% | +16.77% | +384.82% | 433.33 M USD | ||
| 3007 |  BNTC Benitec Biopharma Inc. - Common Stock | 12.88 USD | +4.63% | +1.02% | +8.51% | -22.46% | 442.48 M USD |